Samsung Executive Cuong Do Joins the Company as Independent Board Member
Marketwire Canada - Wed May 04, 7:31AM CDT
BEVERLY, MA--(Marketwired - May 04, 2016) - NanoAntibiotics, Inc. (OTC PINK: NNAB) (the "Company," soon to be known as BioVie Inc.), a development stage company focused on the discovery, development, and commercialization of innovative drug therapies, announced today the appointment of Cuong Do, MBA, as an independent member of the Company's Board of Directors. Mr. Do is currently Executive Vice President, Global Strategy Group for Samsung, where he helps to set the strategic direction for Samsung Group's diverse business portfolio.
MRK: 62.98 (-0.34)
NanoAntibiotics Acquires Company Developing Novel Therapies for Liver Disease
Marketwired - Mon Apr 18, 7:16AM CDT
NanoAntibiotics Inc. (OTCQB: NNAB) (the "Company"